Form 8-K - Current report:
SEC Accession No. 0001628280-20-014431
Filing Date
2020-10-09
Accepted
2020-10-09 17:20:26
Documents
1
Period of Report
2020-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K FOURTH AMENDMENT TO REVOLVING LINE OF CREDIT a8-kdebt10x9x20.htm 8-K 33046
  Complete submission text file 0001628280-20-014431.txt   34106
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 201233969
SIC: 2834 Pharmaceutical Preparations